HEALTH NEWS

Study Title:

Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediate

Study Abstract

Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis. 

Study Information

Acta Pharmacol Sin. 2024 Jan;45(1):150-165. doi: 10.1038/s41401-023-01156-w. Epub 2023 Sep 11. PMID: 37696989; PMCID: PMC10770410. 

Full Study

https://pubmed.ncbi.nlm.nih.gov/37696989/
September Sale

OCTOBER SALE

Energize, strengthen, and protect your health with superior quality daily essentials!